Sterile drug product CDMO services
Products
Information
As a proven leader in the production of biologics and small molecules from first-in-human (FIH) trials to commercial-scale manufacturing, we can help you advance to market quicker. With many format and formulation choices available including lyophilized, we can manufacture the right format for every stage of the product lifecycle. Flexible sterile fill-finish services at our cGMP facilities can accommodate a variety of molecules including biologics and mRNA. For preclinical work, non-cGMP options are also available. Our global teams and regulatory experts have guided numerous projects to successful NDA/BLA approval — we can do the same for you.
All Categories
ParenteralsContract ManufacturingContract PackagingCool Chain (CDMOs and CMOs) (Services)Logistics and DistributionLyophilisationVial/ Syringe FillingDrug Formulation (general category)Aseptic technologyQuality controlSterilizationFormulation developmentTech transfer and Scale upFilling/ Fill Finish & Packaging ServicesInjectable systems and componentsWearable deviceVial/syringe filling servicesSterile Injectables Manufacturing ServicesAseptic Contract Manufacturing Services
Main Categories
Biopharmaceutical ProductsFinished Dosage Forms (Products)Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Packaging Materials and Equipment (Products)Drug Delivery Devices & Systems (Products)Laboratory and Analytical ServicesPharmaceutical Machinery & Technology (Products)Contract Packaging Services
Distribution Areas
OceaniaNorth America (USA, Canada)Middle East Region (e.g. UAE)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
